Showing 2,658 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Real-world responses to HCV treatment among US veterans match best clinical trial results

News
14 November 2016
Hepatitis B

U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

Editor's pick
Gilead press release
11 November 2016
Access to healthcare

These researchers think they have a solution to the global crisis in drug prices

Editor's pick
Washington Post
8 November 2016
Access to healthcare

Buyers clubs for cheaper drugs help fight hepatitis and HIV

Editor's pick
Reuters
7 November 2016
Hepatitis C treatment

The Cost Of A Cure: Revisiting Medicare Part D And Hepatitis C Drugs

Editor's pick
Health Affairs (blog)
4 November 2016
Pharmaceutical industry

Gilead sales of Hepatitis C drugs slump

Editor's pick
MarketWatch
2 November 2016
Access to healthcare

Over 1 million treated with highly effective hepatitis C medicines

Editor's pick
World Health Organization
27 October 2016
Hepatitis C treatment

Generic hepatitis C drugs purchased online achieve high cure rates

News
27 October 2016
Access to healthcare

New $90-$90-$90 target needed for global viral hepatitis, HIV and TB treatment

News
24 October 2016
Hepatitis C treatment

A promising Hep C program seems to be working — and it could be a model for other countries

Editor's pick
Business Insider
24 October 2016
Hepatitis C treatment

Eliminating hepatitis C as a major public health threat needs a two-pronged attack

Editor's pick
Public Health England
18 October 2016
Drug policy & policing

Decriminalization is a public health strategy

Editor's pick
Treatment Action Group
18 October 2016
Hepatitis C treatment

Punjab hepatitis control programme on verge of collapse

Editor's pick
Daily Times
18 October 2016
Hepatitis C treatment

People infected by hepatitis C in Canada have limited access to direct-acting antivirals

Editor's pick
CRCHUM Montreal
17 October 2016
Hepatitis B

Hepatitis B testing should be done before hepatitis C treatment due to risk of HBV reactivation

News
7 October 2016
Pharmaceutical industry

European regulator amends some Gilead hep C patent claims

Editor's pick
STAT
6 October 2016
Hepatitis C treatment

HCV Drugs May Reactivate HBV, FDA Warns

Editor's pick
Medscape (free registration required)
6 October 2016
Hepatitis C treatment

100% cure rate for people with HCV genotype 1 treated with AL-335, odalasvir and simeprevir for 6 or 8 weeks

News
5 October 2016
Hepatitis C treatment

UNITAID and FIND launch initiative to improve diagnostics and treatment for hepatitis C

Editor's pick
UNITAID
4 October 2016
Hepatitis C treatment

Elimination of viral hepatitis by 2030: What's needed and how do we get there?

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
4 October 2016
Hepatitis C transmission & prevention

Hepatitis C infection and reinfection among men who have sex with men need higher priority, US and European studies show

News
30 September 2016
Hepatitis C treatment

Australia leading world in hepatitis C treatment; but disease more prevalent in Aboriginal people

Editor's pick
ABC Online
29 September 2016
Hepatitis C transmission & prevention

Risk of reinfection is a concern after successful hepatitis C treatment

News
28 September 2016
New & experimental hepatitis C treatment

Achillion Announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen’s Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naïve HCV

Editor's pick
Achillion press release
26 September 2016